IP Library Assignment 033778/0426
Patent Assignment
Reel/Frame 033778/0426

Asset Transfer Agreement

Recorded: 2014-09-19 Pages: 195
Assignor
INTERCELL AG
Executed: 2013-01-16
Assignee
INTERCELL AUSTRIA AG
CAMPUS VIENNA BIOCENTER 3, VIENNA, 1030, AUSTRIA
Covered Property (1)
Vaccine Composition Comprising An Antigen And A Peptide Having Adjuvant Properties
Patent: 8,900,564 →
Application: 12/124,785 →
Publication: US 2009/0123486
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 19, 2014
From: FRITZ, JORG; MATTNER, FRANK; ZAUNER, WOLFGANG; NAGY, ESZTER
To: INTERCELL BIOMEDIZINISCHE FORSCHUNGS-UND ENTWICKLUNGS AG
Reel/Frame 033776/0569 →
Change of Name Sep 19, 2014
From: INTERCELL BIOMEDIZINISCHE FORSCHUNGS-UND ENTWICKLUNGS AG
To: INTERCELL AG
Reel/Frame 033776/0617 →
Change of Name Sep 19, 2014
From: INTERCELL AUSTRIA AG
To: VALNEVA AUSTRIA GMBH
Reel/Frame 033776/0800 →
Security Interest Mar 4, 2020
From: VALNEVA SE; VALNEVA USA, INC.; VALNEVA AUSTRIA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052016/0745 →
Release of Security Interest Nov 10, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: VALNEVA AUSTRIA GMBH; VALNEVA SE; VALNEVA USA, INC.
Reel/Frame 073516/0522 →